PRONTO-PEDS: Ultra-Rapid Insulin Lispro in T1D

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

19 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

PRONTO-PEDS will test if a ultra-fast insulin product given before or immediately after meals improves glycemic control in children and teens with type 1 diabetes. The study lasts for 33 weeks and during this time, you and your child will both need to visit the clinic 7 times and reply to at least 9 phone calls. If your child is not currently taking humalog (or lispro), he or she will be transitioned to humalog for a couple of weeks before randomization. Your child will be randomized to receive the new insulin or humalog. In addition to blood and urine tests, your child will have to check their blood sugar between 4-7 times a day and complete a study diary. To be eligible for this study, your child must:

  • Have type 1 diabetes for at least 6 months
  • Be between 1 and 17 years old
  • Have a hemoglobin A1c between =9.9%

Eligibility & Criteria

IRB #:
19-015947
Study Phase:
Phase III
Eligible Age Range:
1 - 17 Years
Gender:
All
Study Categories: